Gift cards from politicalized brands dampen recipients’ gratitude

Scienmag

When liberals and conservatives receive gift cards for politicized brands that clash with their own views, they are less appreciative of the gift-giver’s gesture, new research indicates. Latest News Brands cards dampen gift Gratitude politicalized recipientsPULLMAN, Wash.

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

New study reports need to monitor public interest in shopping and sales of popular Puff Bar e-cigarette brand

Scienmag

ATLANTA, May 12, 2022 – New research led by scientists at the American Cancer Society (ACS) shows the need for continued surveillance of the changes in shopping interest and sales for Puff Bar, the most preferred brand of electronic cigarettes or e-cigarettes among youth in the United States.

Pharmaceutical OTC brands are being outcompeted by private-label OTC brands in retail and e-commerce marketplaces

Bio Pharma Dive

Self-care and the resulting increased use of over-the-counter (OTC) medications is a growing global trend

Brands can boost their own reputations and sales by praising rivals

Scienmag

Whether they’re beefing on billboards or sparring on social media, big brands are known for taking jabs at their competitors (see the famous “Get a Mac” ads or “the chicken sandwich wars”). Social & Behavioral Science boost Brands praising reputations rivals sales

Have you checked your brand’s temperature?

Pharma Phorum

In today’s fast-paced world how do you make sure your brand messages resonate with your customers and, if they do, how can your brand become even more remarkable? How healthy is your brand? The best treatment for brand diseases is ‘action copywriting’. of the brand.

New patent for Teva Branded drug PROAIR DIGIHALER

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

Free Online Course on Drug Patents, Generic and Branded Drugs

Drug Patent Watch

DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry. The post Free Online Course on Drug Patents, Generic and Branded Drugs appeared first on DrugPatentWatch - Make Better Decisions.

Emotional empathy is driving brand equity

Pharma Phorum

How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic in better shape than ever. Non-pharma brands leading by example.

Generic Portfolio Management, Partnering with Brands, and Staying Competitive

Drug Patent Watch

The post Generic Portfolio Management, Partnering with Brands, and Staying Competitive appeared first on DrugPatentWatch - Make Better Decisions. This is my talk from the 14th Annual Portfolio Planning and Partnership for Generic Conference.

New patent for Teva Branded drug PROAIR RESPICLICK

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

Six Women-Owned Food Brands to Support Beyond International Women’s Day 2022

XTalks

Women-owned food brands have made some remarkable strides in the food and beverage industry. To celebrate Women’s History Month and International Women’s Day on March 8, there are countless woman-owned-and-operated food brands to support beyond the month of March.

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

COVID-19 Vaccine Brand Names: Moderna Secures Spikevax in Europe While Pfizer is Comirnaty

XTalks

Moderna has won approval from the European Medicines Association (EMA) for branding its COVID-19 vaccine with the name Spikevax. With the approval, Moderna’s Spikevax joins Pfizer-BioNTech’s Comirnaty and AstraZeneca’s Vaxzevria with European brand-name approvals.

Simply Better Brands Corp. Completes Business Acquisition

BioTech 365

Simply Better Brands Corp. Completes Business Acquisition Simply Better Brands Corp. Completes Business Acquisition VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) — Simply Better Brands Corp?. the “Company” or “Simply Better Brands?”) (TSX Venture: SBBC, OTCQB: PKANF)?, announces today … Continue reading → GlobeNewswire

Branding Science opens new office in Germany

Pharma Phorum

The healthcare brand consultancy Branding Science has opened a new office in Germany. . “With its diverse and creative atmosphere, Berlin is a perfect fit for Branding Science and our company culture!” News Sales and Marketing Branding Science comms

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

Cost of brand-name epilepsy drugs increased by 277% over eight years

Scienmag

MINNEAPOLIS – The cost of brand-name drugs for epilepsy increased by 277% from 2010 to 2018, according to a study published in the June 15, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.The cost of generic drugs for epilepsy decreased by 42% over the same period. Brand-name drugs made […].

DOJ Re-Brands Guidance Documents

FDA Law Blog

This policy, announced by then Associate Attorney General Rachel Brand in 2018 was referred to as the Brand Memo. As a matter of administrative law, the Brand Memo made good sense from the perspective of FDA-regulated industry, as we described here. By Anne K.

Celebrating Our New Brand: EVERSANA INTOUCH !

Intouch Solutions

We unveiled our new brand – EVERSANA INTOUCH – and had celebrations across many of our offices to mark the occasion with some fun and cameraderie! Our new brand is the next step in our journey of joining EVERSANA , which began last year.

New patent for Teva Branded drug PROAIR DIGIHALER

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

New patent for Teva Branded drug PROAIR RESPICLICK

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

This Software Company Helps CPG Brands Manage Excess Inventory

XTalks

Spoiler Alert , a Boston-based software company that helps perishable consumer packaged goods (CPG) brands manage excess inventory, announced on Wednesday that it raised $11 million in a series A funding round.

US Branded Generics Market to Reach $172.03 Million by 2027 from $77.9 Million in 2022 – ResearchAndMarkets.com

BioTech 365

US Branded Generics Market to Reach $172.03 Million in 2022 – ResearchAndMarkets.com US Branded Generics Market to Reach $172.03 Million in 2022 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Branded Generics Market Research … Continue reading → Business WireMillion by 2027 from $77.9 Million by 2027 from $77.9

Chalice Brands Ltd. Announces Late Filing of Annual Financial Statements

BioTech 365

Chalice Brands Ltd. Announces Late Filing of Annual Financial Statements Chalice Brands Ltd. May 03, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. CSE: CHAL) (OTCQB: CHALF) (the “Company” or “Chalice Brands”) … Continue reading → GlobeNewswireAnnounces Late Filing of Annual Financial Statements PORTLAND, Ore.,

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

Simply Better Brands Corp. Announces Shares For Debt Transaction

BioTech 365

Simply Better Brands Corp. Announces Shares For Debt Transaction Simply Better Brands Corp. Announces Shares For Debt Transaction VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) — Simply Better Brands Corp. (“SBBC” or the “Company“) (TSX Venture: SBBC, OTCQB: PKANF) … Continue reading → GlobeNewswire

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

Chalice Brands Ltd. Announces Appointment of Richard Lindsay as Interim Chief Financial Officer

BioTech 365

Chalice Brands Ltd. Announces Appointment of Richard Lindsay as Interim Chief Financial Officer Chalice Brands Ltd. June 23, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. Announces Appointment of Richard Lindsay as Interim Chief Financial Officer PORTLAND, Ore., CSE: CHAL) (OTCQB: … Continue reading → GlobeNewswire

Supply chain middlemen ‘pocket half of US branded medicine spending’

Pharma Phorum

In 2020, over half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders, overtaking the amount going to drug manufacturers for the first time, according to a new study.

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

CATO SMS Unveils New Brand

BioTech 365

–(BUSINESS WIRE)–CATO SMS unveiled its new brand today, revealing an updated look and logo capturing the company’s powerful offering following the merger of CATO Research, LLC and Specialized Medical Services-oncology BV (SMS-oncology). CARY, N.C.–(BUSINESS

Bringing Health Influencers Into Your Brand

Intouch Solutions

They can be gatekeepers to their audiences and authenticators of brand messaging, serving as extended voices of a brand. The post Bringing Health Influencers Into Your Brand appeared first on Intouch Solutions. Today, the voices of influencers are vital.

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

MOMI Brands, Inc. Closes $1M Seed Round

BioTech 365

MOMI Brands, Inc. Closes $1M Seed Round MOMI Brands, Inc. –(BUSINESS WIRE)–#babyproducts—MOMI Brands, Inc. Closes $1M Seed Round Former Medela president launches startup to commercialize new breast pump and infant feeding technologies WINSTON-SALEM, N.C.–(BUSINESS

New patent for Teva Branded drug PROAIR DIGIHALER

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

New patent expiration for Teva Branded drug PROAIR RESPICLICK

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent expiration for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

Doctor’s Ed Solution – Brand New Angle

The Pharma Data

Product Name: Doctor’s Ed Solution – Brand New Angle. Doctor’s Ed Solution – Brand New Angle is backed with a 60 Day No Questions Asked Money Back Guarantee.

Brand New "primal" Beauty Offer For Women!

The Pharma Data

Product Name: Brand New "primal" Beauty Offer For Women! Click here to get Brand New "primal" Beauty Offer For Women! Brand New "primal" Beauty Offer For Women! Description: Click here to get Brand New "primal" Beauty Offer For Women!

Chalice Brands Ltd. Announces Delay in Filing of Annual Financial Statements

BioTech 365

Chalice Brands Ltd. Announces Delay in Filing of Annual Financial Statements Chalice Brands Ltd. June 15, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. Announces Delay in Filing of Annual Financial Statements PORTLAND, Ore., CSE: CHAL) (OTCQB: CHALF) (the “Company” or … Continue reading → GlobeNewswire

Chalice Brands Ltd. Continues Sequential Revenue Growth

BioTech 365

Chalice Brands Ltd. Continues Sequential Revenue Growth Chalice Brands Ltd. 26, 2021 (GLOBE NEWSWIRE) — Chalice Brands … Continue reading → GlobeNewswireContinues Sequential Revenue Growth Reports Second Quarter 2021 Revenues of $6.9 Million and Third Consecutive Quarter of Positive Adjusted EBITDA(1) PORTLAND, Ore.,